Reine Pharma SRL
2.6 FTEReine Pharma reported total assets of €1.03m at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Aug 2026), with 2.6 full-time equivalents.
By total assets for 2025, Reine Pharma ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Reine Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +237 % Total assets -10 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Reine Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 19 Aug 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
Reine Pharma's financial analysis
- Solvency12.2%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Reine Pharma
Reine Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0643.728.226
- VAT number
- BE0643728226
- Peppol
- Registered · 0208:0643728226 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Nov 2015
- Registered office
- 1000 Brussels
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Reine Pharma (SRL) has been based in Brussels since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 53,748 € and equity of 125,834 €; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 12.2%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Reine Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Van Gelder Retail sale of pharmaceutical products Colfontaine · balance sheet €1.09m
- Dekerk Retail sale of pharmaceutical products Tienen · balance sheet €1.12m
- Mendeljev Retail sale of pharmaceutical products Beernem · balance sheet €1.14m
- Apotheek Verachtert-Gysen Retail sale of pharmaceutical products Pelt · balance sheet €1.04m
- Piers Retail sale of pharmaceutical products Ostend · balance sheet €1.05m
- Farmacie Céline Desmet Retail sale of pharmaceutical products Heuvelland · balance sheet €1.06m
- W.A. Farma Retail sale of pharmaceutical products Kontich · balance sheet €1.09m
- Medifar Retail sale of pharmaceutical products Meerhout · balance sheet 921,854 €
Frequently asked questions about Reine Pharma
What is the revenue of Reine Pharma?
Reine Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Reine Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0643728226 for Reine Pharma, if the company is VAT-registered. Its company number (CBE) is 0643.728.226.
Where is the registered office of Reine Pharma?
According to the CBE register, the registered office of Reine Pharma is in 1000 Brussels.
What is the equity of Reine Pharma?
At the close of the 2025 financial year, the equity of Reine Pharma amounts to 125,834 €, a solvency of 12.2% of total assets.
How many people work at Reine Pharma?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Reine Pharma?
The register lists 2 active mandates at Reine Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Reine Pharma within its sector?
By total assets for 2025, Reine Pharma ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Reine Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →